Shanna Burke to Apolipoprotein E4
This is a "connection" page, showing publications Shanna Burke has written about Apolipoprotein E4.
Connection Strength
2.916
-
Burke SL, Hu T, Spadola CE, Li T, Naseh M, Burgess A, Cadet T. Mild cognitive impairment: associations with sleep disturbance, apolipoprotein e4, and sleep medications. Sleep Med. 2018 12; 52:168-176.
Score: 0.634
-
Burke SL, Hu T, Spadola CE, Burgess A, Li T, Cadet T. Treatment of Sleep Disturbance May Reduce the Risk of Future Probable Alzheimer's Disease. J Aging Health. 2019 02; 31(2):322-342.
Score: 0.632
-
Burke SL, Maramaldi P, Cadet T, Kukull W. Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry. 2018 Jan; 33(1):200-211.
Score: 0.579
-
Burke SL, Maramaldi P, Cadet T, Kukull W. Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease development. Arch Gerontol Geriatr. 2016 Jul-Aug; 65:231-8.
Score: 0.536
-
Burke SL, Maramaldi P, Cadet T, Kukull W. Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia. Int Psychogeriatr. 2016 09; 28(9):1409-24.
Score: 0.534